<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:18:08Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/19685" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/19685</identifier><datestamp>2026-10-18T21:11:48Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Effects of epilepsy control following decompressive craniectomy on mortality and morbidity in epileptic patients with malignant MCA infarction</dc:title><dc:creator>ÇAKIR, TAYFUN</dc:creator><dc:creator>YÜCETAS, SEYHO CEM</dc:creator><dc:creator>Kafadar, Huseyin</dc:creator><dc:creator>Gezgin, inan</dc:creator><dc:subject>Genel ve Dahili Tıp</dc:subject><dc:subject>Patoloji</dc:subject><dc:subject>Nörolojik Bilimler</dc:subject><dc:description>Aim: The present study aims to investigate the effects of seizure or epilepsy formation on mortality and morbidity in epilepticpatients after craniectomy.Material and Methods: The patients were divided into the following groups: Group 1, those who had no seizures, but were routinelytreated with 3x100 mg of epanutin daily (n=6), Group 2, those who had at least one or multiple seizures and were initiated a secondantiepileptic drug in addition to 3x100 mg of epanutin daily (n=13), and Group 3, those who had multiple seizures and who weresedated or narcotized in addition to being treated with 3x100 mg of epanutin daily (n=7). All patients underwent decompressivecraniectomy within a maximum period of 48 hours and their characteristics such as age, gender, localization of infarct, hemiplegia,monoplegia, operation time, Glasgow coma and outcome scales were recorded.Results: According to the Glasgow Outcome Scale, 1 patient in Group 1, 8 patients in Group 2 and 6 patients in Group 3 died and therewas a signifiant increase in patient losses in Group 2 and Group 3 compared to Group 1 (p&lt;0.05). 10 patients continued to live theirlives with the support of home-care services and 2 patients with other forms of help.Conclusion: It was seen that there is a high incidence of seizure and epilepsy in MMCA infarcts after decompressive craniectomy andthis signifiantly increased mortality or dysfunctional recovery if epilepsy could not be brought under control.</dc:description><dc:date>2020</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/19685</dc:identifier><dc:identifier>https://doi.org/10.5455/annalsmedres.2020.01.022</dc:identifier><dc:language>en</dc:language><dc:relation>Annals of Medical Research</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/19685</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>